Recent Articles from GlobeNewswire

Los Angeles, California, Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Lundquist Institute is proud to announce that its Medical-Financial Partnership (MFP), co-directed by Monique Holguin, LCSW, PhD, and Adam Schickedanz, MD, PhD, has been awarded a $3.44 million grant from the Conrad N. Hilton Foundation. This award will expand and sustain the MFP’s groundbreaking approach to addressing the powerful connection between financial stability and family health.  

BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- On Thursday, November 13, 2025, the Board of Directors of Cabot Corporation (NYSE: CBT) declared a quarterly dividend of $0.45 per share on all outstanding shares of the Corporation’s common stock. The dividend is payable on December 12, 2025, to stockholders of record at the close of business on November 28, 2025.

- Grew Total Revenue 10% Year-over-Year to $137.0 Million -

CALGARY, Alberta, Nov. 13, 2025 (GLOBE NEWSWIRE) -- South Bow Corp. (TSX & NYSE: SOBO) (South Bow or the Company) reports its third-quarter 2025 financial and operational results and provides its 2026 outlook. Unless otherwise noted, all financial figures in this news release are in U.S. dollars.

A new chapter in decentralized finance — delivering predictable returns, renewable energy integration, and reinforced security for a changing economy.

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors Quantum Corporation (NASDAQ: QMCO), Unicycive Therapeutics, Inc. (NASDAQ: UNCY), Fly-E Group, Inc. (NASDAQ:FLYE), and Lantheus Holdings, Inc. (NASDAQ:LNTH) on behalf of long-term stockholders. More information about each potential case can be found at the link provided.

Atlanta, GA., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The King Center, in collaboration with New Birth Missionary Baptist Church and The King’s Table, is proud to announce a community food distribution event on Saturday, November 15, 2025, from 12:00 PM to 2:00 PM ET. Taking place at The King Center (449 Auburn Ave, NE, Atlanta, GA 30312), the event aims to provide fresh produce and essential groceries to families in need while supplies last. This initiative reflects a shared commitment to service, dignity, and the beloved community envisioned by Dr. Martin Luther King, Jr. and Mrs. Coretta Scott King. 

New insights from Spherix Global Insights reveal strong rheumatologist anticipation for next-generation oral and multi-pathway innovations, including Sotyktu, icotrokinra, and sonelokimab.

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) --

Total Revenue up 38% and Recurring Free Cash Flow up 15% year-over-year

VANCOUVER, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Skeena Resources Limited (TSX: SKE, NYSE: SKE) (“Skeena Gold & Silver”, “Skeena” or the “Company”) reports interim financial results for the quarter ended September 30, 2025. The interim financial statements and management’s discussion and analysis (“MD&A”) are available on Skeena’s website and have been posted under the Company’s profile on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov.

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025.

GUELPH, Ontario, Nov. 13, 2025 (GLOBE NEWSWIRE) -- (TSX: HPS.A) The Board of Directors of Hammond Power Solutions Inc. (“HPS”) declared a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class A Subordinate Voting Share of HPS and a quarterly cash dividend of twenty-seven and a half cents ($0.275) per Class B Common Share of HPS payable on December 18, 2025, to shareholders of record at the close of business on December 11, 2025. The ex-dividend date is December 11, 2025.

HOUSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SEACOR Marine Holdings Inc. (NYSE:SMHI) (the “Company” or “SEACOR Marine”), a leading provider of marine and support transportation services to offshore energy facilities worldwide, today announced that it has published its 2024-2025 Sustainability Report. The report documents SEACOR Marine’s continued commitment to the environment, its employees and its responsibility as a global citizen.

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) --

SAN FRANCISCO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in upcoming investor events.

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Figure Technology Solutions, Inc. (“FTS”) today announced that it has confidentially submitted a draft registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the "SEC"), relating to the proposed public offering of its Series A Blockchain Common Stock, par value $0.0001 per share (the “Tokenized Stock”). The Tokenized Stock will not be listed on any legacy exchange, but will trade on Figure’s alternative trading system and will be convertible into shares of Class A Common Stock on a one-for-one basis.

Adjusted EBITDA from continuing operations of $1.2 million for the nine months ended September 30, 2025, compared to a loss of $0.1 million in the year ago period

SAN DIEGO and TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS and OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), today announced financial results for the third quarter ended September 30, 2025, and provided a corporate update.

Highlights

TEJON RANCH, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co. (the “Company”) (NYSE:TRC), a diversified real estate development and agriculture company, today issued a public letter from President and Chief Executive Officer Matthew Walker to their shareholders, ahead of the Company’s Investor Engagement Event, being held tomorrow at the New York Stock Exchange in New York City.

GREENWICH, Conn., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Stardust Power Inc. (“Stardust Power” or the “Company”) (Nasdaq: SDST), an American developer of battery-grade lithium carbonate, today announced its results for the third quarter ended September 30, 2025.  

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM) is pleased to announce that its previously announced proposed investment transaction (the “Transaction”) with The Global South S.A.S., as outlined in the management information circular (the “Circular”) dated October 9, 2025, has been approved by the Company’s minority shareholders at the Company’s Special Meeting of Shareholders held on November 12th, 2025.

MIAMI, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced financial results for the third quarter ending September 30, 2025, and provided business highlights.

TSXV: OML OTCQX: OLNCF

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Brookfield Asset Management Ltd. (“BAM”) (NYSE: BAM, TSX: BAM) a leading global alternative asset manager headquartered in New York with over $1 trillion of assets under management, today announced the pricing of a public offering of (i) $600 million principal amount of senior notes due 2030, which will bear interest at a rate of 4.653% per annum (the “2030 notes”), and (ii) $400 million principal amount of senior notes due 2036, which will bear interest at a rate of 5.298% per annum (the “2036 notes” and, together with the 2030 notes, the “notes”).

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Fluor (FLR) To Contact Him Directly To Discuss Their Options

THE WOODLANDS, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- TWFG Insurance announced a series of pivotal leadership appointments designed to accelerate the company’s growth and strengthen its position for continued industry innovations.

KUALA LUMPUR, Malaysia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS, NASDAQ: BGMSP; "BGMS" or the "Company" (formerly Cyclacel Pharmaceuticals, Inc.)), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update.

INSIDE INFORMATIONREGULATED INFORMATION

Technology leader celebrates its permanent presence in Riyadh following nearly two years of embedded partnership with Riyadh Air

~ Pivotal Financial Turnaround Completed, Fortifying the Foundation for Renewed Operational Momentum ~

Commercial revenue grew 37%, driven by AI risk assistant adoption

Raleigh, NC, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Raleigh, NC— Premier destination for aesthetic excellence in Raleigh, Lyle Plastic Surgery and Aesthetics Center, is proud to unveil its latest innovation in wellness and body transformation: the GLP-1 Wellness Program. Spearheaded by board-certified plastic surgeon Dr. Glenn Lyle, this medically supervised program offers a breakthrough approach to weight loss using advanced GLP-1 receptor agonists, including semaglutide and tirzepatide.

Atlanta, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Piedmont Realty Trust, Inc. (the “Company” or “Piedmont”) (NYSE:PDM) announced today that its operating partnership, Piedmont Operating Partnership, LP (the “Operating Partnership”), has priced an offering of $400 million aggregate principal amount of 5.625% senior notes due 2033 at 99.364% of the principal amount. The offering is expected to close on November 20, 2025, subject to the satisfaction of customary closing conditions.

MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered direct offering of 4,189,000 shares of its common stock at a price of $1.11 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase 7,523,000 shares of common stock at an offering price of $1.1099 per pre-funded warrant, which represents the per share offering price for the shares of common stock less the $0.0001 per share exercise price. The gross proceeds to TELA from the offering, before deducting underwriting discounts and estimated offering expenses, are expected to be approximately $13.0 million, assuming no exercise of the pre-funded warrants. The offering is expected to close on or about November 17, 2025, subject to the satisfaction of customary closing conditions.

PARIS and CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced advancements for its next-wave Curadigm Nanoprimer platform.

Accelsius recently secured strategic investment from Johnson Controls and introduced its NeuCool® MR250 system; pipeline of opportunities now exceeds $1 billion

SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today reported its third quarter 2025 operating and financial results and reviewed recent business highlights. 

Highlights:

Sales Revenue Up 135% over Q3 2024

REGULATED INFORMATION

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Figure Technology Solutions (Nasdaq: FIGR), the leading blockchain-native capital marketplace for the origination, funding, sale and trading of tokenized assets, today announced financial results for the quarter ended September 30, 2025. “We recently completed our successful initial public offering and are pleased to report a strong first quarter as a public company. The continued success of Figure’s marketplace approach to tokenized consumer loan origination drove significant growth in earnings, with Net Income increasing 227% year-over-year while also achieving an Adjusted EBITDA margin of 55%, underscoring the scalability of our blockchain-based model. Alongside margin expansion, we delivered solid performance across our key metrics, consumer loan marketplace volume, Adjusted Net Revenue, and growth across our blockchain ecosystem pillars, positioning Figure to finish 2025 with continued momentum.”- Michael Tannenbaum, CEO Q3 2025 Financial Highlights

Former Nationwide CMO Brings Over 25 years of P&C Insurance and Digital Marketing Expertise

Announced completion of dose exploration portion of ORIC-944 Phase 1b clinical trial and presented data that continues to demonstrate potential best-in-class efficacy and safety

Advancement of ACR-368 in registrational-intent Phase 2b trial for the treatment of patients with endometrial cancer

SAN JOSE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Astera Labs (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will participate in the following upcoming financial conferences during the fourth quarter 2025:

Efficacy data remain consistent with prior disclosure and continue to demonstrate broad and deep PSA responses, with 55% PSA50 response rate and 20% PSA90 response rate

LONDON and GAITHERSBURG, Md., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the Company will participate in the Jefferies Global Healthcare Conference in London.

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT), a commerce media solutions provider, today reported unaudited financial results for the third quarter ended September 30, 2025.

Collections Grow 63% to $236.8 Million and Deployments Grow 22% to $151.0 MillionPre-tax Income up 16% to $45.5 Million with Net Income of $38.4 Million and EPS of $0.59Adjusted Pre-tax Income up 30% to $54.8 Million with Adjusted Net Income of $47.7 Million and Adjusted EPS of $0.74Board of Directors Declares Quarterly Cash Dividend of $0.24 per Share

CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended September 30, 2025 and updated its full year 2025 guidance.

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced financial results for the quarter ending September 30, 2025, and provided a corporate update.

IRVINE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, electrical and other critical infrastructure construction services, today announced financial results for the third quarter ended October 3, 2025.

Q3 2025 Sales Growth of 72% to $2.4 Million Driven by Continued Demand for Battery Products, Accessories and Technologies

TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, today reported unaudited financial results for the third quarter ended September 30, 2025. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.S. generally accepted accounting principles (U.S. GAAP).  

VISTA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today reported financial and operational results for the 2026 fiscal first quarter ended September 30, 2025.

With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum continues toward achieving 2027 targeted initial LATAM Rice revenue

Aardvark has aligned with the FDA to reduce the minimum age of eligibility from 13 to 10 years old for pediatric patients in HERO, the Phase 3 trial of ARD-101 for the treatment of hyperphagia associated with Prader-Willi Syndrome (PWS)

AIRJ Expands Strategic Partnerships and Advances Productization of AirJoule™ Systems Ahead of Commercial Deployments in 2026

WILMINGTON, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, will report financial results for its third quarter ended October 31, 2025, after the market close on Wednesday, December 3, 2025. nCino will host a conference call and webcast that day at 4:30 p.m. ET to discuss its financial results.

MENLO PARK, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for October 2025.

SAN JUAN, Puerto Rico, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Red Cat Holdings, Inc.  (Nasdaq: RCAT) ("Red Cat" or the "Company"), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, reports its financial results for the third quarter ended September 30, 2025.

Delivered 130 units and generated $16.5 million in revenue

Maris-Tech will Obtain Controlling Interest in the New Company

Launches New High-Performing XTM Mining Products to Support Revenue Growth in Q4 2025

Partnership deployed touchless prior authorization system in eight weeks, achieving 95% reduction in authorization workload

Southfield, Michigan, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today the completion of a $500.0 million asset-backed non-recourse secured financing (the “Financing”).  Pursuant to this transaction, we conveyed loans having a value of approximately $625.2 million to a wholly owned special purpose entity which will transfer the loans to a trust, which will issue three classes of notes:

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), a leading developer of the world’s largest resource of critical metals essential to energy, defense, manufacturing and infrastructure, today provided a corporate update and third quarter results for the period ending September 30, 2025.

SANTA CLARA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Applied Materials, Inc. (NASDAQ: AMAT) today reported results for its fourth quarter and fiscal year ended Oct. 26, 2025.

CALGARY, Alberta, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces third quarter results for the period ended September 30, 2025.

Multiple Late-Stage Data Readouts Reinforce Telitacicept’s Broad Potential Across Autoimmune DiseasesExpansion of Executive Leadership and Board Strengthens Global Development Capabilities

MALVERN, Pa., Nov. 13, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the third quarter ended September 30, 2025.

Third quarter 2025 worldwide net sales totaled $270 million

BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today reported financial results for the third quarter ended September 30, 2025, and provided recent corporate and clinical updates.